Why Analysts Believe RAC is “Highly Undervalued”, page-9

I had this at work during a luncheon today. Someone saw me checking Stocks and asked about it.

Even my colleagues look at me like I'm delusional with regards to FTO. But the second you mention cardioprotection.. "What company is it, i'll keep an eye on it".

My response is generally "When we actually move, keeping a eye out will be too late".

Then comes the crazy look again when looking at the SP action over last few years followed by my now canned response of: "Well, if you look at all biotechs pre and post covid".

I have no doubts the price action has turned away many, and if that behaviour is typical, then it begets more floundering price action .